Understanding Thalix
Thalix 100 mg is a pharmaceutical-grade thalidomide preparation manufactured by Natco Pharmaceuticals Ltd. Thalidomide is an immunomodulatory compound that has been extensively studied in laboratory settings for its unique mechanism of action on cellular signalling pathways. This compound exhibits anti-angiogenic and anti-inflammatory properties that make it valuable for in-vitro research applications investigating immune system modulation and cellular responses.
Research scientists at Stroid UK Shop utilise thalidomide preparations to examine its effects on tumour necrosis factor-alpha production, T-cell proliferation, and angiogenesis inhibition in controlled laboratory environments. The compound’s ability to modulate multiple inflammatory pathways provides researchers with a versatile tool for studying immune-related cellular mechanisms.
Laboratory Research Applications
Thalidomide serves multiple research purposes in cellular biology studies. Scientists investigate its immunomodulatory effects through analysis of cytokine production patterns, particularly its selective inhibition of TNF-alpha synthesis in peripheral blood mononuclear cells. The compound’s anti-angiogenic properties are examined through endothelial cell culture studies, where researchers evaluate its impact on vascular endothelial growth factor pathways and capillary tube formation assays.
Research facilities studying inflammatory conditions utilise thalidomide to examine its effects on nuclear factor-kappa B signalling cascades and inflammatory mediator expression. Additionally, scientists analyse its impact on T-helper cell differentiation and regulatory T-cell function in immunological research protocols. The compound’s ability to cross the blood-brain barrier makes it particularly valuable for neuroinflammation studies examining microglial activation and central nervous system immune responses.
Laboratories focusing on selective androgen receptor modulators and peptide research often incorporate thalidomide studies to understand comparative immunomodulatory mechanisms across different compound classes available through specialised research suppliers.
Chemical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Thalidomide |
| Strength | 100 mg per tablet |
| CAS Number | 50-35-1 |
| Molecular Formula | C₁₃H₁₀N₂O₄ |
| Molecular Weight | 258.23 g/mol |
| Manufacturer | Natco Pharmaceuticals Ltd. |
| Storage Conditions | Room temperature, dry environment |
| Shelf Life | Verify with supplier documentation |
Research Compliance Statement
Thalix 100 mg tablets are supplied exclusively for in-vitro laboratory research purposes and are not intended for human consumption or therapeutic applications. Researchers must maintain appropriate laboratory safety protocols when handling this compound and ensure compliance with institutional research guidelines. All studies should be conducted under appropriate ethical oversight with proper documentation of research methodologies and safety procedures. This product is intended solely for qualified research institutions and licensed laboratories conducting legitimate scientific investigations into immunomodulatory mechanisms and cellular pathway research.
